THE SEMA3E-PLEXIN D1-NRP2 TRIAD IN ENZALUTAMIDE RESISTANCE AND NEUROENDOCRINE PROSTATE CANCER

$554,219FY2019Defense Health AgencyDOD

Washington State University, Pullman WA

Investigators